Načítá se...
In silico modeling for quick prediction of inhibitory activity against 3CL(pro) enzyme in SARS CoV diseases
As of 2 September 2020, the 2019 novel coronavirus or SARS CoV-2 has been responsible for more than 2,56,02,665 infections and 8,52,768 deaths worldwide. There has been an urgent need of newer drug discovery to tackle the situation. Severe acute respiratory syndrome-associated coronavirus 3C-like pr...
Uloženo v:
| Vydáno v: | J Biomol Struct Dyn |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7544940/ https://ncbi.nlm.nih.gov/pubmed/32954984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1821779 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|